An update on inflammatory breast cancer

P. Thapaliya, N. J. Karlin

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Inflammatory breast cancer is one of the most aggressive forms of breast cancer. Once considered to be a uniformly fatal disease, treatment of this entity has evolved significantly over the last two decades. In this article, we review the epidemiology, pathology, biologic underpinnings, radiologic advances, and treatment modalities for inflammatory breast cancer. Updates in surgical therapy, medical oncologic therapy and radiation therapy are reviewed. Emphasis is on cutting edge information regarding inflammatory breast cancer. The management of inflammatory breast cancer is best served by a multidisciplinary team. Continued research into molecular pathways and potential targets is imperative. Future clinical trials should include evaluation of conventional therapy with targeted therapies.

Original languageEnglish (US)
Pages (from-to)73-78
Number of pages6
JournalOncology Reviews
Volume3
Issue number2
DOIs
StatePublished - Jun 2009

Fingerprint

Inflammatory Breast Neoplasms
Therapeutics
Epidemiology
Radiotherapy
Clinical Trials
Pathology
Breast Neoplasms
Research

Keywords

  • Breast cancer
  • Inflammatory
  • Lymphovascular invasion
  • Metastasis

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

An update on inflammatory breast cancer. / Thapaliya, P.; Karlin, N. J.

In: Oncology Reviews, Vol. 3, No. 2, 06.2009, p. 73-78.

Research output: Contribution to journalArticle

Thapaliya, P & Karlin, NJ 2009, 'An update on inflammatory breast cancer', Oncology Reviews, vol. 3, no. 2, pp. 73-78. https://doi.org/10.1007/s12156-009-0010-y
Thapaliya, P. ; Karlin, N. J. / An update on inflammatory breast cancer. In: Oncology Reviews. 2009 ; Vol. 3, No. 2. pp. 73-78.
@article{0cab3cf040374a79bcfb3dfd2cf756dc,
title = "An update on inflammatory breast cancer",
abstract = "Inflammatory breast cancer is one of the most aggressive forms of breast cancer. Once considered to be a uniformly fatal disease, treatment of this entity has evolved significantly over the last two decades. In this article, we review the epidemiology, pathology, biologic underpinnings, radiologic advances, and treatment modalities for inflammatory breast cancer. Updates in surgical therapy, medical oncologic therapy and radiation therapy are reviewed. Emphasis is on cutting edge information regarding inflammatory breast cancer. The management of inflammatory breast cancer is best served by a multidisciplinary team. Continued research into molecular pathways and potential targets is imperative. Future clinical trials should include evaluation of conventional therapy with targeted therapies.",
keywords = "Breast cancer, Inflammatory, Lymphovascular invasion, Metastasis",
author = "P. Thapaliya and Karlin, {N. J.}",
year = "2009",
month = "6",
doi = "10.1007/s12156-009-0010-y",
language = "English (US)",
volume = "3",
pages = "73--78",
journal = "Oncology Reviews",
issn = "1970-5557",
publisher = "PagePress",
number = "2",

}

TY - JOUR

T1 - An update on inflammatory breast cancer

AU - Thapaliya, P.

AU - Karlin, N. J.

PY - 2009/6

Y1 - 2009/6

N2 - Inflammatory breast cancer is one of the most aggressive forms of breast cancer. Once considered to be a uniformly fatal disease, treatment of this entity has evolved significantly over the last two decades. In this article, we review the epidemiology, pathology, biologic underpinnings, radiologic advances, and treatment modalities for inflammatory breast cancer. Updates in surgical therapy, medical oncologic therapy and radiation therapy are reviewed. Emphasis is on cutting edge information regarding inflammatory breast cancer. The management of inflammatory breast cancer is best served by a multidisciplinary team. Continued research into molecular pathways and potential targets is imperative. Future clinical trials should include evaluation of conventional therapy with targeted therapies.

AB - Inflammatory breast cancer is one of the most aggressive forms of breast cancer. Once considered to be a uniformly fatal disease, treatment of this entity has evolved significantly over the last two decades. In this article, we review the epidemiology, pathology, biologic underpinnings, radiologic advances, and treatment modalities for inflammatory breast cancer. Updates in surgical therapy, medical oncologic therapy and radiation therapy are reviewed. Emphasis is on cutting edge information regarding inflammatory breast cancer. The management of inflammatory breast cancer is best served by a multidisciplinary team. Continued research into molecular pathways and potential targets is imperative. Future clinical trials should include evaluation of conventional therapy with targeted therapies.

KW - Breast cancer

KW - Inflammatory

KW - Lymphovascular invasion

KW - Metastasis

UR - http://www.scopus.com/inward/record.url?scp=67650649965&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67650649965&partnerID=8YFLogxK

U2 - 10.1007/s12156-009-0010-y

DO - 10.1007/s12156-009-0010-y

M3 - Article

AN - SCOPUS:67650649965

VL - 3

SP - 73

EP - 78

JO - Oncology Reviews

JF - Oncology Reviews

SN - 1970-5557

IS - 2

ER -